je.st
news
Asahi Kasei Pharma Selects Evotec As Its Partner For Ion Channel Drug Discovery
2015-04-01 08:17:32| drugdiscoveryonline Home Page
Evotec AG recently announced it has entered into a multi-target screening collaboration on several ion channel targets, with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei Corporation, Tokyo, Japan. Under the terms of the agreement, Evotec will use its world-class ion channel platform to identify inhibitors of multiple ion channel targets
Tags: partner
channel
drug
discovery
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||